CLINICAL_TRIALS ClinicalTrials.gov record update

ANG-015 / MLU-3 (CHARTER Study): Characterization of Circulating Tumor Cells Isolated Using the Parsortix® System in High Risk and Early Metastatic Prostate Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05437679
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:36.115931+00:00
Published At: 2023-09-05T00:00:00+00:00
Record Updated At: 2023-09-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["High Risk Prostate Carcinoma", "Biochemically Recurrent Prostate Carcinoma", "Castration-resistant Prostate Cancer", "Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-09-05"
protocolSection.identificationModule.nctId: "NCT05437679"
protocolSection.identificationModule.officialTitle: "ANG-015 / MLU-3 (CHARTER Study): Characterization of Circulating Tumor Cells Isolated Using the Parsortix\u00ae System in High Risk and Early Metastatic Prostate Cancer Patients"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.